Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload.

Nicolas Mercure-CorriveauElizabeth P CroweSonja VozniakXinyi FengHerleen RaiTayler Van DenakkerAbdulhafiz ZakiehM Kate GrabowskiSophie LanzkronAaron A R Tobian Evan M Bloch

Published in: Transfusion (2023)

Our findings suggest that EAT is safe and effective to treat patients with SCD and severe anemia, who are at risk for TACO. EAT requires fewer RBC units compared to automated RBC exchange.

Keyphrases

sickle cell disease
chronic kidney disease
machine learning
deep learning
iron deficiency
high throughput
early onset
red blood cell
drug induced
extracorporeal membrane oxygenation
single cell